Filing Details

Accession Number:
0001140361-15-025097
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-22 21:57:21
Reporting Period:
2015-06-18
Filing Date:
2015-06-22
Accepted Time:
2015-06-22 21:57:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070698 Raptor Pharmaceutical Corp RPTP Pharmaceutical Preparations (2834) 860883978
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420859 E Thomas Daley C/O Raptor Pharmaceutical Corp.
7 Hamilton Landing, Suite 100
Novato CA 94949
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-18 30,000 $15.00 34,719 No 4 S Direct
Common Stock Acquisiton 2015-06-18 5,000 $3.54 39,719 No 4 M Direct
Common Stock Disposition 2015-06-18 5,000 $15.00 34,719 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Options (Right To Buy) Common Stock Acquisiton 2015-06-18 5,000 $0.00 5,000 $3.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,864 2020-11-22 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014.
  2. Includes 11,500 Restricted Stock Units ("RSUs") granted on February 9, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
  3. Fully vested and exercisable.